LAB
Standard BioTools·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LAB
Standard Biotools Inc.
A leading provider of innovative life science tools and reagents for research and diagnostics
Life Science Tools and Services
05/19/1999
02/10/2011
NASDAQ Stock Exchange
814
12-31
Common stock
2 Tower Place, Suite 2000, South San Francisco, CA 94080
--
Standard BioTools Inc., was founded in California on May 19, 1999. The company creates, manufactures and sells innovative technologies and tools for life science research. The company is driven by a bold goal — unleashing tools to accelerate breakthroughs in human health. The company develops, manufactures and sells technologies that help biomedical researchers find faster and better ways to develop drugs. The company's tools use proprietary large-scale cytology and microfluidic technologies to provide health and disease insights for applications in proteomics and genomics, respectively.
Earnings Call
Q1/2025
Estimate EPS-0.04
Actual EPS-0.07
Estimate Revenue40.10M
Actual Revenue40.80M
Standard BioTools Q1 2025: Contradictions in Instrument Demand, Revenue Forecasts, and Academic Funding Trends
May 07,2025 07:28
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LAB has released its 2025 Q3 earnings. EPS was reported at -0.09, versus the expected -0.02, missing expectations. The chart below visualizes how LAB has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LAB has released its 2025 Q3 earnings report, with revenue of 19.55M, reflecting a YoY change of -11.47%, and net profit of -34.69M, showing a YoY change of -28.77%. The Sankey diagram below clearly presents LAB's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
